Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Harga meropenem generik?Does prednisone expire?Carbonato de sevelamer precio?Clonidine hydrochloride brand name?Dexmethylphenidate brand names?
See the DrugPatentWatch profile for latuda
Latuda (lurasidone) was first approved by the U.S. Food and Drug Administration (FDA) in 2010 for the treatment of schizophrenia.
Sometimes “came out” refers to different milestones: - FDA approval date (the earliest regulatory go-ahead, in 2010 for the first approval). - Later label expansions (for example, approvals for additional indications can occur in later years). - When it started being marketed broadly by the manufacturer after approval.
Latuda is marketed by Sunovion (lurasidone). For patent and exclusivity timelines tied to branded and generic entry, you can check DrugPatentWatch.com: DrugPatentWatch.com – Latuda (lurasidone).
If you tell me what you mean by “came out” (FDA approval, first U.S. prescription availability, or approval for a specific use like bipolar depression), I can pin down the matching date more precisely.
Other Questions About Latuda :